We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$804M
AUM Growth
-$371M
Cap. Flow
-$448M
Cap. Flow %
-55.74%
Top 10 Hldgs %
23.79%
Holding
602
New
17
Increased
28
Reduced
122
Closed
126
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASCAW
451
DELISTED
A SPAC I Acquisition Corp. Warrant
ASCAW
$984 ﹤0.01%
56,250
ALSAW
452
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$875 ﹤0.01%
100,000
ANGHW icon
453
Anghami Inc Warrants
ANGHW
$793 ﹤0.01%
26,889
-33,111
-55% -$1.38K
KACLW
454
DELISTED
Kairous Acquisition Corp. Limited Warrants
KACLW
$734 ﹤0.01%
48,800
NSTB.WS
455
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$463 ﹤0.01%
13,493
LFACW
456
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$311 ﹤0.01%
103,600
SDSTW
457
Stardust Power Inc Warrant
SDSTW
$283 ﹤0.01%
89,938
ATMCR
458
DELISTED
AlphaTime Acquisition Corp Right
ATMCR
-80,000
Closed -$10.8K
BAERW icon
459
Bridger Aerospace Warrant
BAERW
$8.48M
-229,000
Closed -$52K
COEPW
460
DELISTED
Coeptis Therapeutics Warrants
COEPW
-70,506
Closed -$5.25K
ESLAW icon
461
Estrella Immunopharma Warrant
ESLAW
$138K
-50,000
Closed -$2.62K
GDEVW icon
462
GDEV Inc Warrant
GDEVW
$56.7K
-148,156
Closed -$21.9K
GRRRW
463
Gorilla Technology Group Warrant
GRRRW
$1.82M
-46,340
Closed -$6.26K
ICUCW
464
SeaStar Medical Holding Corp Warrant
ICUCW
-243,106
Closed -$8.21K
MDAIW icon
465
Spectral AI Warrants
MDAIW
$5.45M
-100,000
Closed -$5.5K
MRT icon
466
Marti Technologies
MRT
$150M
-62,017
Closed -$657K
PET
467
DELISTED
Wag!
PET
-25,323
Closed -$53.2K
PSQH.WS icon
468
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
-54,879
Closed -$43K
PYXS icon
469
Pyxis Oncology
PYXS
$236M
$0 ﹤0.01%
+53,288
New +$123K
RDZNW icon
470
Roadzen Inc Warrants
RDZNW
$8.64M
-125,000
Closed -$4.83K
RDZN icon
471
Roadzen
RDZN
$112M
-254,508
Closed -$2.71M
SDAWW
472
SunCar Technology Group Warrant
SDAWW
-125,310
Closed -$45.7K
SKYH.WS icon
473
Sky Harbour Group Warrants
SKYH.WS
$21.4M
-32,593
Closed -$9.52K
SPWR icon
474
SunPower Inc
SPWR
$53.8M
-408,960
Closed -$4.33M
SWVLW icon
475
Swvl Holdings Corp Warrant
SWVLW
-86,420
Closed -$1.32K

Similar funds

Radcliffe Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Radcliffe Capital Management held 602 positions worth $804M, down 32% from $1.17B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Radcliffe Capital Management withdrew a net $448M in Q3 2023, closing 126 positions and reducing 122 holdings. Its most notable exit was SilverSPAC Inc. Class A Ordinary Share, an estimated $21.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 55% of assets, down from 57% a quarter earlier, followed by Technology and Industrials.

Against the trend, Radcliffe Capital Management opened a new position in USA Rare Earth Inc worth $7.66M.

  • Radcliffe Capital Management's largest Q3 2023 buy was USA Rare Earth Inc: 750,000 shares worth $7.66M.
  • Radcliffe Capital Management added most to Concord Acquisition Corp II in Q3 2023, an estimated $5.66M increase.
  • Radcliffe Capital Management's biggest Q3 2023 reduction was Project Energy Reimagined Acquisition Corp. Class A Ordinary Share, cutting an estimated $19.8M.
  • Radcliffe Capital Management fully exited SilverSPAC Inc. Class A Ordinary Share in Q3 2023, selling an estimated $21.1M.
  • Radcliffe Capital Management's ten largest holdings make up 24% of its $804M portfolio in Q3 2023.
  • Radcliffe Capital Management opened 17 new positions and closed 126 in Q3 2023.
  • Radcliffe Capital Management's portfolio value fell 32% quarter-over-quarter to $804M.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.